NCT06495125 2025-04-17Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung CancerEmory UniversityPhase 2 Recruiting50 enrolled
NCT03681483 2024-07-10RO5126766 for Patients With Advanced KRAS-Mutant Lung CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed15 enrolled